The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 22, 2012
Filed:
Oct. 16, 2007
Peter H. Dobbelaar, Morris Plains, NJ (US);
Christopher L. Franklin, Keasbey, NJ (US);
Allan Goodman, Media, PA (US);
Cheng Guo, Schenectady, NY (US);
Peter R. Guzzo, Niskayuna, NY (US);
Mark Hadden, Albany, NY (US);
Shuwen He, Edison, NJ (US);
Alan J. Henderson, Albany, NY (US);
Tianying Jian, Westfield, NJ (US);
Linus S. Lin, Westfield, NJ (US);
Jian Liu, Edison, NJ (US);
Ravi P. Nargund, East Brunswick, NJ (US);
Megan Ruenz, Grayslake, IL (US);
Bruce J. Sargent, Delmar, NY (US);
Iyassu K. Sebhat, Jersey City, NJ (US);
Larry Yet, Albany, NY (US);
Peter H. Dobbelaar, Morris Plains, NJ (US);
Christopher L. Franklin, Keasbey, NJ (US);
Allan Goodman, Media, PA (US);
Cheng Guo, Schenectady, NY (US);
Peter R. Guzzo, Niskayuna, NY (US);
Mark Hadden, Albany, NY (US);
Shuwen He, Edison, NJ (US);
Alan J. Henderson, Albany, NY (US);
Tianying Jian, Westfield, NJ (US);
Linus S. Lin, Westfield, NJ (US);
Jian Liu, Edison, NJ (US);
Ravi P. Nargund, East Brunswick, NJ (US);
Megan Ruenz, Grayslake, IL (US);
Bruce J. Sargent, Delmar, NY (US);
Iyassu K. Sebhat, Jersey City, NJ (US);
Larry Yet, Albany, NY (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Albany Molecular Research, Inc., Albany, NY (US);
Abstract
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.